Abstract 1739 Generation of AAV9 Gene Therapy Capsid Variants Capable of Evading Neutralizing anti-AAV9 Antibodies derived from Patients Post-Zolgensma® Treatment
Journal of biological chemistry/The Journal of biological chemistry